Hailemichael D Mekonnen MD, PhD
banner
hailemichaeld.bsky.social
Hailemichael D Mekonnen MD, PhD
@hailemichaeld.bsky.social
#Hepatology, Director Sub-Saharan Africa Gastroenterology iECHO
Reposted by Hailemichael D Mekonnen MD, PhD
The May 2025 issue of The Lancet Gastroenterology & Hepatology is out now at www.thelancet.com/gastrohep!

Including content on achalasia, kidney injury in cirrhosis, viral hepatitis, alcohol use disorder, inflammatory bowel disease, liver cancer & more.

#GastroSky #MedSky #OncSky #IDSky #LiverSky
April 10, 2025 at 5:32 AM
Join us for a biweekly educational series @projectechohq.bsky.social
February 25, 2025 at 12:23 AM
Reposted by Hailemichael D Mekonnen MD, PhD
TAF reduces the risk of liver-related serious adverse events in adults w/ non-cirrhotic chronic hepatitis B & moderate or high viraemia but normal/mildly elevated ALT

Data suggest guidelines should allow early therapy in patients with a moderate or high viral load

#LiverSky #MedSky #IDSky #HepSky
New research - Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trial

tinyurl.com/4cvdy6h2

#LiverSky #IDSky #MedSky #HepSky
February 4, 2025 at 6:06 AM
Reposted by Hailemichael D Mekonnen MD, PhD
The Lancet Gastroenterology & Hepatology is now on Bluesky!

bsky.app/profile/lanc...

Follow us!

#GastroSky #LiverSky #MedSky
bsky.app
February 3, 2025 at 3:24 PM
Join us for an educational series @projectechohq.bsky.social
January 9, 2025 at 9:16 PM
Clinical significance Vs statistical significance
nejm.org NEJM.org @nejm.org · Dec 24
In the TB-CHAMP randomized, controlled trial involving children with household exposure to multidrug-resistant tuberculosis, levofloxacin led to a lower incidence of tuberculosis than placebo, but the difference was not significant. Full trial results: nej.md/41AXgQd

#MedSky #IDSky
December 25, 2024 at 12:24 AM
How 🐒 resist #Hepatitis B infection? #aminoacid differences in #NTCP species barriers for viruses #SARS-COV-2
December 15, 2024 at 11:55 PM
Reposted by Hailemichael D Mekonnen MD, PhD
New Comment - Elimination of hepatitis B requires recognition of catastrophic costs for patients and their families

www.thelancet.com/journals/lan...

@pippa-matt.bsky.social

#HepSky #IDSky #LiverSky #MedSky
December 14, 2024 at 6:32 AM
Reposted by Hailemichael D Mekonnen MD, PhD
🧵 Combination Therapy for Chronic HBV Infection (a thread)

Chronic hepatitis B virus (HBV) affects more than 3% of the world population and is responsible for approximately 1.1 million deaths annually.

Full article: nej.md/49nfu9F 1/15

#MedSky
December 9, 2024 at 7:43 PM
Reposted by Hailemichael D Mekonnen MD, PhD
6. Church of St. George

This church is one of eleven in Ethiopia carved from solid rock, dating to the late 12th or early 13th century AD.
November 28, 2024 at 12:10 AM
Reposted by Hailemichael D Mekonnen MD, PhD
Over 800 million adults are now living with #diabetes worldwide with more than half not receiving treatment, global analysis suggests.

Explore the findings ▶️ bit.ly/3Be89wl
November 28, 2024 at 12:07 PM
Happy thanksgiving
November 28, 2024 at 11:27 PM
November 25, 2024 at 9:45 PM
Reposted by Hailemichael D Mekonnen MD, PhD
Our latest issue came out last week, with an Editorial on incretin mimetics & obesity, new research on MASLD, intestinal ultrasound in IBD, HBV, & predicting CSPH. Also a great pair of reviews on IBS: one on diet, the other on personalised medicine

www.thelancet.com/gastrohep

#GastroSky #LiverSky
November 12, 2024 at 3:18 PM